-

$undefined

N/A

(N/A)

Genelux Corporation :GNLX

Location: | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

73.95M

Cash

33.64M

Avg Qtr Burn

-5.361M

Short % of Float

3.72%

Insider Ownership

16.29%

Institutional Own.

18.97%

Qtr Updated

06/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Olvi-Vec (Olvimulogene nanivacirepvec) + platinum-doublet + bevacizumab Details Cancer, Platinum-resistant ovarian cancer, Ovarian cancer	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Olvi-Vec (Olvimulogene nanivacirepvec) Details Cancer, Non-small cell lung carcinoma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Olvi-Vec (Olvimulogene nanivacirepvec) Details Cancer, Small cell lung cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.